Saturday, July 11, 2026

Drug profile · INN

laninamivir octanoate hydrate

laninamivir octanoate hydrate (INAVIR INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.

PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — laninamivir octanoate hydrate
Class
Route
Patents
0
Programs
0
Data quality
0.78

Quick answer

laninamivir octanoate hydrate (INAVIR INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN laninamivir octanoate hydrate
Brand INAVIR INITIAL APPROVAL

Approval history

Authority Status Date
PMDA approved

Frequently asked questions

What is laninamivir octanoate hydrate?

laninamivir octanoate hydrate (INAVIR INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for laninamivir octanoate hydrate?

INAVIR INITIAL APPROVAL is a marketed brand name for laninamivir octanoate hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.